Advisor Group Holdings, Inc. Gamida Cell Ltd. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.85 - $1.87 $34 - $74	-40 Reduced 0.16%	24,241 $24,000
Q2 2023 Aug 10, 2023	BUY	$0.73 - $2.37 $15,505 - $50,341	21,241 Added 698.72%	24,281 $46,000
Q1 2023 May 12, 2023	BUY	$0.68 - $1.71 $1,789 - $4,500	2,632 Added 645.1%	3,040 $2,000
Q2 2022 Aug 10, 2022	SELL	$1.73 - $4.29 $865 - $2,145	-500 Reduced 55.07%	408 $1,000
Q1 2022 May 04, 2022	SELL	$2.22 - $4.47 $2,157 - $4,344	-972 Reduced 51.7%	908 $4,000
Q1 2021 May 13, 2021	BUY	$7.8 - $12.43 $14,664 - $23,368	1,880 New	1,880 $15,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.